Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 1631 entries
View as:

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.

Phase: N/A Priority: Normal
NCT ID: NCT00750113 Org: User:
Start: 10/31/07 End: 08/31/09 Due: 08/31/10

Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT03603678 Org: User:
Start: 08/13/18 End: 09/02/19 Due: 09/02/20

Sun Protection Factor Assay (341/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02995135 Org: User:
Start: 01/03/17 End: 01/06/17 Due: 01/06/18

A Study to Learn More About How a Smartphone App Called MyIUS Predicts Future Menstrual Bleeding in Women After They Have Begun Using Intrauterine Birth Control Method (a Birth Control Device is Inserted Into a Woman's Uterus by Her Doctor)

Phase: N/A Priority: Normal
NCT ID: NCT04989595 Org: User:
Start: 09/17/21 End: 02/27/24 Due: 02/27/25

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)

Phase: N/A Priority: Normal
NCT ID: NCT01855100 Org: User:
Start: 07/31/13 End: 12/31/14 Due: 12/31/15

Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed

Phase: N/A Priority: Normal
NCT ID: NCT01350609 Org: User:
Start: 04/30/11 End: 09/30/11 Due: 09/30/12

LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study

Phase: N/A Priority: Normal
NCT ID: NCT01397097 Org: User:
Start: 09/30/11 End: 04/30/15 Due: 04/30/16

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04356989 Org: User:
Start: 05/13/20 End: 01/16/23 Due: 01/16/24

A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin

Phase: N/A Priority: Normal
NCT ID: NCT01164696 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

Effects of SH T00658ID on Libido

Phase: N/A Priority: Normal
NCT ID: NCT00764881 Org: User:
Start: 01/31/09 End: 07/31/10 Due: 07/31/11

Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion

Phase: N/A Priority: Normal
NCT ID: NCT01958684 Org: User:
Start: 10/31/13 End: 10/31/14 Due: 10/31/15

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00332020 Org: User:
Start: 02/28/06 End: 06/30/07 Due: 06/30/08

A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease

Phase: N/A Priority: Normal
NCT ID: NCT03161912 Org: User:
Start: 11/24/17 End: 12/17/21 Due: 12/17/22

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Phase: N/A Priority: Normal
NCT ID: NCT01295294 Org: User:
Start: 03/31/11 End: 12/31/11 Due: 12/31/12

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Phase: N/A Priority: Normal
NCT ID: NCT01674647 Org: User:
Start: 10/31/12 End: 01/31/14 Due: 01/31/15

Diabetes Treatment With Glucobay in Combination With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01612741 Org: User:
Start: 04/30/08 End: 01/31/09 Due: 01/31/10

Investigation of Mass Balance of the Test Drug and Major Metabolites

Phase: N/A Priority: Normal
NCT ID: NCT00432302 Org: User:
Start: 01/31/07 End: 11/30/07 Due: 11/30/08

Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies

Phase: N/A Priority: Normal
NCT ID: NCT02610153 Org: User:
Start: 10/01/15 End: 03/15/19 Due: 03/15/20

The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure

Phase: N/A Priority: Normal
NCT ID: NCT06779942 Org: User:
Start: 12/15/24 End: 12/31/24 Due: 12/31/25

15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)

Phase: N/A Priority: Normal
NCT ID: NCT02021370 Org: User:
Start: 02/10/14 End: 09/23/15 Due: 09/23/16

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

Phase: N/A Priority: Normal
NCT ID: NCT03588299 Org: User:
Start: 11/07/18 End: 11/03/26 Due: 11/03/27

Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02200614 Org: User:
Start: 09/12/14 End: 06/14/21 Due: 06/14/22

The Effects of BAY1193397 on Skin Capillary Blood Flow and Transcutaneous Oxygen Pressure

Phase: N/A Priority: Normal
NCT ID: NCT03128320 Org: User:
Start: 05/25/17 End: 10/28/19 Due: 10/28/20

A Study to Learn More About How Well BAY 2927088 Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Phase: N/A Priority: Normal
NCT ID: NCT06452277 Org: User:
Start: 08/28/24 End: 04/26/29 Due: 04/26/30

18616 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02788162 Org: User:
Start: 10/19/15 End: 10/21/15 Due: 10/21/16